Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
05/22/2001 | US6235778 Anticoagulants |
05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
05/22/2001 | US6235680 N-acylsulfonamides, novel mixtures of herbicides and antidotes, and their use |
05/17/2001 | WO2001034596A2 Pyrrolecarbonylimino derivatives as naaladase inhibitors |
05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
05/17/2001 | WO2001034580A1 Heterocycle substituted diphenyl leukotriene antagonists |
05/17/2001 | WO2001034567A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
05/17/2001 | WO2001034558A1 Chemically modified supports and process for producing the same |
05/17/2001 | WO2001034135A2 Oncolytic combinations for the treatment of cancer |
05/17/2001 | CA2391230A1 Heterocycle substituted diphenyl leukotriene antagonists |
05/17/2001 | CA2390789A1 Oncolytic combinations for the treatment of cancer |
05/17/2001 | CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
05/16/2001 | EP1099691A1 N-Sulfonyloxyimide compound and radiation-sensitive resin composition using the same |
05/16/2001 | EP1098892A1 Biphenyl derivatives |
05/16/2001 | EP1098877A1 Derivatized polymers of alpha-olefin-maleic anhydride alkyl half-ester or full acid |
05/16/2001 | EP1098866A1 Method for producing ortho-alkylated benzoic acid derivatives |
05/16/2001 | EP1098666A2 Water-soluble drugs and methods for their production |
05/16/2001 | EP1039886A4 Hiv/fiv protease inhibitors having a small p3 residue |
05/16/2001 | EP0769003B1 Amino acid-derived diaminopropanols |
05/16/2001 | CN1295561A N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
05/16/2001 | CN1295471A Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
05/16/2001 | CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor |
05/15/2001 | US6232476 Intermediates in a process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine |
05/15/2001 | US6232475 Reacting a substituted bromobenzene with n-vinylimide; catalytic hydrogenation |
05/15/2001 | US6232467 Biosynthesis of an amine with ketone and boron compound; compoundlibraries |
05/15/2001 | US6232430 Cross-linkers for cross-linkable optical polycarbonates |
05/15/2001 | US6232356 Reactive catalyst compositions for improving water blown polyurethane foam performance |
05/15/2001 | US6232338 4-Mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
05/15/2001 | US6232329 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles |
05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
05/15/2001 | US6232258 Oxygenation catalyst and process for producing a ketone using the same |
05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
05/10/2001 | WO2001032618A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
05/10/2001 | WO2001032602A1 Diaryl-enynes |
05/10/2001 | WO2001019908A3 Recovery of modifier compounds and polar organic compounds from a poly(arylene sulfide) recycle mixture |
05/10/2001 | WO2000078714A3 Succinimides as paper sizing agents |
05/10/2001 | DE19953025A1 Pyrrolderivate als Phosphodiesterase VII-Hemmer Pyrrole derivatives as phosphodiesterase VII inhibitor |
05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
05/10/2001 | CA2387660A1 Diaryl-enynes as glycine transport inhibitors |
05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
05/09/2001 | EP1097382A2 Imidazoline receptor binding compounds |
05/09/2001 | EP1097152A2 Synthesis of compounds useful in the manufacture of ketorolac |
05/09/2001 | EP1097134A1 Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers |
05/09/2001 | EP1097128A1 Imidamide derivatives |
05/09/2001 | EP1097117A2 Aryl vinyl ether derivatives and their use as herbicides |
05/09/2001 | EP1096931A2 Use of (s) (-)-amisulpride for the manufacture of a medicament for the treatment of schizophrenia |
05/09/2001 | CN1294577A 钾通道抑制剂 Potassium channel inhibitors |
05/09/2001 | CN1294568A Fluorinating agent, process for producing same, and use thereof |
05/09/2001 | CN1294125A Method for recovering N-vinyl-2-pyrrolidone |
05/09/2001 | CN1065527C Guanidine derivatives, process for producing same and cosmetics contg. same |
05/08/2001 | US6229020 Reacting n-succinimidyl and p-nitrophenyl cinnamate derivatives with physiologically active substance such as an amino acid; protecting amino or hydroxy groups for analysis of biological reactions by irradiation with light |
05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
05/08/2001 | US6228872 Neurotrophic diamide and carbamate agents |
05/08/2001 | US6228847 Inhibitors of nucleoside metabolism |
05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
05/03/2001 | WO2001030756A1 Benzamidine derivatives |
05/03/2001 | WO2001030755A1 Process for the production of n-methyl pyrrolidone using gamma butyrolactone and mixed methylamines as starting materials |
05/03/2001 | WO2001030745A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
05/03/2001 | WO2001010839A3 Multivalent substituted ketoamides and amides for treating hair loss |
05/03/2001 | CA2388684A1 Process for the production of n-methyl pyrrolidone using gamma butyrolactone and mixed methylamines as starting materials |
05/02/2001 | EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
05/02/2001 | EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
05/02/2001 | EP0946097B1 Composition and use |
05/02/2001 | CN1293666A Benzenesulfonamide-derivatives and their use as medicaments |
05/02/2001 | CN1293189A Beta-halogamma-hydroxypyrrolidone and its synthesis process |
05/01/2001 | US6225437 Useful as internal and external sizing agents for paper and paper products |
05/01/2001 | US6225351 For therapy of asthma, arthritis, and sepsis bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis, sepsis, septic shock, cachexia, acquire immuno deficiency syndrome (aids) |
05/01/2001 | US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection |
05/01/2001 | US6224665 Process for the preparation of highly chromatic perylene pigments |
05/01/2001 | CA2001265C Analogs of peptidase substrates |
04/26/2001 | WO2001028999A1 Process for the preparation of amorphous atorvastatin calcium |
04/26/2001 | WO2001028998A1 N-substituted perfluoroalkylated pyrrolidines, process for making them and process for the addition of rf-iodide to an olefin |
04/26/2001 | WO2001028997A2 Synthesis of 4-substituted pyrrole-2-carbaldehyde compounds |
04/26/2001 | WO2001028996A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases |
04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
04/26/2001 | DE19860972A1 Verfahren zur Herstellung derivatisierter Polymere A process for preparing derivatized polymers |
04/26/2001 | CA2388859A1 Inhibitors of neuraminidases |
04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
04/25/2001 | EP1094061A1 Process for recovering N-Vinyl-2-Pyrrolidone |
04/25/2001 | EP1093454A1 Chiral compounds and their use as doping agents in liquid crystals |
04/25/2001 | EP0701568B1 New peptide derivatives |
04/24/2001 | US6222043 Coupling 2-amido-thiazole derivative with 2-phenyl4-(protected)amino-butyric acid; deprotecting amino protecting group; acylating product with carboxylic acid containing carbocyclic or heterocyclic group; deprotecting |
04/24/2001 | US6222032 Conducting the c-alkylation or n-alkylation reaction in the presence of a slightly nucleophilic strong base comprising a phosphorus compound |
04/24/2001 | US6222013 Esterifying amino acid or peptide by mixing with alkanol and chlorosulfonic acid; alcohol reacts with chlorosulfonic acid to form a hydrosulfate which then reacts with amino acid or peptide for form corresponding ester |
04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |